Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

They're known to aid in blood sugar control and, now, weight loss — but, according to a sweeping new study, the popular GLP-1 ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Gad then revealed that he had started taking a GLP-1 for weight loss, and that so far he had ... I'm figuring out this new one, and it is life-changing." However, he also stressed: "But it ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...